[Apelin-APJ system: from discovery to therapeutic target].
Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA 90095, USA. akasai@mednet.ucla.edu
Atsushi
A
Kasai
D000818:Animals; D000073861:Apelin; D000075244:Apelin Receptors; D001161:Arteriosclerosis / Q000209:etiology / Q000628:therapy; D003930:Diabetic Retinopathy / Q000209:etiology / Q000628:therapy; D016222:Fibroblast Growth Factor 2 / Q000502:physiology; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000502:physiology*; D058990:Molecular Targeted Therapy; D009389:Neovascularization, Pathologic / Q000209:etiology* / Q000628:therapy; D043562:Receptors, G-Protein-Coupled / Q000502:physiology*; D042461:Vascular Endothelial Growth Factor A / Q000502:physiology
C115436:APLN protein, human; C104575:APLNR protein, human; D000073861:Apelin; D000075244:Apelin Receptors; D036341:Intercellular Signaling Peptides and Proteins; D043562:Receptors, G-Protein-Coupled; D042461:Vascular Endothelial Growth Factor A; D016222:Fibroblast Growth Factor 2